Evidence map›Paper›PMID 37765152›Full record

ArticlePharmaceutics2023

Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years.

Gavriela Voulgaridou, Theodora Paraskeva, Georgia Ragia, Natalia Atzemian, Konstantina Portokallidou, George Kolios, Konstantinos Arvanitidis, Vangelis G Manolopoulos

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Gavriela VoulgaridouLaboratory of Pharmacology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Theodora ParaskevaLaboratory of Pharmacology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Georgia RagiaLaboratory of Pharmacology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Natalia AtzemianLaboratory of Pharmacology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0009-0005-7793-7082
Konstantina PortokallidouLaboratory of Pharmacology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
George KoliosLaboratory of Pharmacology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0002-2066-4782
Konstantinos ArvanitidisLaboratory of Pharmacology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0003-0639-2474
Vangelis G ManolopoulosLaboratory of Pharmacology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0003-0849-5469
Democritus University of Thrace · GR

Funding

Financial support for project IMPReS was provided by the Program "Competi-tiveness, Entrepreneurship and Innovation" (NSRF 2014-2020) co-financed by Greece and the European Union (European Regional Development Fund). MIS 5047189
6 · The paper itself

Abstract

Therapeutic drug monitoring (TDM) is the clinical practice of measuring drug concentrations. TDM can be used to determine treatment efficacy and to prevent the occurrence or reduce the risk of drug-induced side effects, being, thus, a tool of personalized medicine. Drugs for which TDM is applied should have a narrow therapeutic range and exhibit both significant pharmacokinetic variability and a predefined target concentration range. The aim of our study was to assess the current status of TDM in Greek public hospitals and estimate its progress over the last 20 years. All Greek public hospitals were contacted to provide data and details on the clinical uptake of TDM in Greece for the years 2003 and 2021 through a structured questionnaire. Data from 113 out of 132 Greek hospitals were collected in 2003, whereas for 2021, we have collected data from 98 out of 122 hospitals. Among these, in 2003 and 2021, 64 and 51 hospitals, respectively, performed TDM. Antiepileptics and antibiotics were the most common drug categories monitored in both years. The total number of drug measurement assays decreased from 2003 to 2021 (153,313 ± 7794 vs. 90,065 ± 5698;

Indexed as

antibioticsantiepilepticsdigoxinGreecehospitalsimmunosuppressantspharmacogenomicspsychiatric drugssubstances of abusetherapeutic drug monitoring

Identifiers

PMID37765152
PMCPMC10535589
OpenAlexW4386098299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.